We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HRTX market cap is 243.35M. The company's latest EPS is USD -0.7269 and P/E is -2.19.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31.76M | 31.43M | 34.23M | 34.67M | 36.02M |
| Operating Income | -42.4M | -24.93M | -10.22M | -4.8M | -6.45M |
| Net Income | -42.06M | -25.01M | -10.72M | -3.16M | -9.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 145.97M | 88.64M | 86.35M | 107.67M | 127.04M |
| Operating Income | -210.69M | -228.16M | -217.83M | -177.55M | -110.62M |
| Net Income | -204.75M | -227.28M | -220.68M | -184.91M | -110.56M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 201.22M | 229.2M | 222.51M | 217.89M | 218.14M |
| Total Liabilities | 240.51M | 256.99M | 256.48M | 251.65M | 256.08M |
| Total Equity | -39.28M | -27.79M | -33.97M | -33.77M | -37.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 512.78M | 353.56M | 305.71M | 250.95M | 222.51M |
| Total Liabilities | 108.95M | 117.06M | 228.14M | 237.38M | 256.48M |
| Total Equity | 403.84M | 236.49M | 77.57M | 13.57M | -33.97M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -52.07M | -61.24M | -58.79M | -9.52M | -14.12M |
| Investing | 50.05M | 26.83M | 18M | 1.28M | 3.33M |
| Financing | 111k | 53.91M | 54.11M | 11k | 503k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -124.58M | -184.82M | -203.35M | -146.91M | -58.79M |
| Investing | -21.78M | 208.96M | 32.73M | -3.32M | 18M |
| Financing | 186.43M | 9.11M | 156.03M | 75.06M | 54.11M |
| Market Cap | 243.35M |
| Price to Earnings Ratio | -2.19 |
| Price to Sales Ratio | 1.9 |
| Price to Cash Ratio | 8.44 |
| Price to Book Ratio | -7.12 |
| Dividend Yield | - |
| Shares Outstanding | 152.09M |
| Average Volume (1 week) | 1.7M |
| Average Volume (1 Month) | 6.65M |
| 52 Week Change | -11.11% |
| 52 Week High | 3.93 |
| 52 Week Low | 1.04 |
| Spread (Intraday) | 0.1 (6.25%) |
| Company Name | Heron Therapeautics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.herontx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
